
  
    
      
        Introduction_NNP
        In_IN 1962_CD ,_, Norman_NNP Stoll_NNP ,_, the_DT distinguished_VBD Rockefeller_NNP Institute_NNP scientist_NN who_WP helped_VBD to_TO
        establish_VB human_JJ parasitology_NN research_NN in_IN North_NNP America_NNP ,_, described_VBD the_DT unique_JJ health_NN impact_NN
        of_IN hookworm_NN as_IN follows_VBZ [_NN 1_CD ]_NN :_: 
        
          As_IN it_PRP was_VBD when_WRB I_PRP first_RB saw_VBD it_PRP ,_, so_IN it_PRP is_VBZ now_RB ,_, one_CD of_IN the_DT most_RBS evil_NN of_IN infections_NNS ._. Not_RB
          with_IN dramatic_JJ pathology_NN as_IN are_VBP filariasis_NNS ,_, or_CC schistosomiasis_NNS ,_, but_CC with_IN damage_NN silent_JJ and_CC
          insidious_JJ ._. Now_RB that_DT malaria_NN is_VBZ being_VBG pushed_VBN back_RB hookworm_NN remains_VBZ the_DT great_JJ infection_NN of_IN
          mankind_NN ._. In_IN my_PRP$ view_NN it_PRP outranks_VBZ all_DT other_JJ worm_NN infections_NNS of_IN man_NN combined_VBD …_NN in_IN its_PRP$
          production_NN ,_, frequently_RB unrealized_JJ ,_, of_IN human_JJ misery_NN ,_, debility_NN ,_, and_CC inefficiency_NN in_IN the_DT
          tropics_NNS ._.
        
        Like_IN many_JJ other_JJ global_JJ disease_NN experts_NNS who_WP witnessed_VBN dramatic_JJ reductions_NNS in_IN malaria_NN
        prevalence_NN as_IN a_DT result_NN of_IN DDT_NNP spraying_VBG during_IN the_DT late_JJ 1950_CD s_VBZ [_NN 2_CD ]_NN ,_, Stoll_NNP did_VBD not_RB anticipate_VB
        malaria_NN 's_POS imminent_JJ re-emergence_NN in_IN India_NNP ._. However_RB ,_, he_PRP articulated_JJ with_IN eloquence_NN the_DT
        magnitude_NN of_IN the_DT disease_NN burden_NN resulting_VBG from_IN hookworm_NN infection_NN ._. He_PRP further_RBR offered_VBD the_DT
        silent_JJ and_CC insidious_JJ character_NN of_IN hookworm_NN as_IN a_DT partial_JJ explanation_NN for_IN its_PRP$ neglect_NN by_IN the_DT
        global_JJ medical_JJ community_NN ._.
        This_DT neglect_NN subsequently_RB intensified_VBD during_IN the_DT 1970_CD s_VBZ ,_, 1980_CD s_VBZ ,_, and_CC 1990_CD s_VBZ with_IN the_DT
        omission_NN of_IN hookworm_NN from_IN the_DT list_NN of_IN diseases_NNS covered_VBN by_IN the_DT World_NNP Health_NNP Organization_NNP 's_POS
        Special_JJ Programme_NNP for_IN Research_NNP and_CC Training_NNP in_IN Tropical_NNP
        
          Hookworm_NNP has_VBZ proven_VBN to_TO be_VB extremely_RB difficult_JJ to_TO eliminate_VB or_CC eradicate_VB in_IN areas_NNS of_IN
          poverty_NN and_CC poor_JJ sanitation_NN ._.
        
        Diseases_NNP ,_, as_RB well_RB as_IN from_IN other_JJ global_JJ health_NN initiatives_NNS ._. Over_IN the_DT last_JJ ten_CD years_NNS ,_,
        however_RB ,_, there_EX has_VBZ been_VBN increasing_VBG recognition_NN of_IN the_DT global_JJ health_NN importance_NN of_IN hookworm_NN ._.
        Today_NN ,_, new_JJ international_JJ efforts_NNS to_TO control_VB the_DT morbidity_NN of_IN hookworm_NN and_CC other_JJ
        soil-transmitted_JJ helminth_NN infections_NNS are_VBP in_IN progress_NN (_( www_NN ._. who_WP ._. int_NN /_NN wormcontrol_NN )_) ._.
      
      
        Etiology_NNP and_CC Global_NNP Distribution_NN
        Human_JJ hookworm_NN infection_NN is_VBZ caused_VBN by_IN blood-feeding_JJ nematode_NN parasites_NNS of_IN the_DT genus_JJ 
        Ancylostoma_NNP and_CC the_DT species_NNS 
        Necator_NNP americanus_JJ ._. Worldwide_NNP ,_, 
        N_NNP ._. americanus_JJ is_VBZ the_DT predominant_NN etiology_NN of_IN human_JJ hookworm_NN
        infection_NN ,_, whereas_IN 
        A_DT ._. duodenale_NN occurs_VBZ in_IN more_RBR scattered_JJ focal_JJ environments_NNS [_NN 3_CD ]_NN ._.
        These_DT two_CD hookworms_NNS ,_, together_RB with_IN the_DT roundworm_NN ,_, 
        Ascaris_NNP lumbricoides_NNS ,_, and_CC the_DT whipworm_NN ,_, 
        Trichuris_NNP trichiura_NN ,_, are_VBP often_RB referred_VBN to_TO collectively_RB as_IN
        soil-transmitted_JJ helminths_NNS (_( STHs_NNP )_) ._.
        No_DT international_JJ surveillance_NN mechanisms_NNS are_VBP in_IN place_NN to_TO determine_VB the_DT prevalence_NN and_CC
        global_JJ distribution_NN of_IN hookworm_NN infection_NN ._. However_RB ,_, based_VBN on_IN an_DT extensive_JJ search_NN of_IN the_DT
        literature_NN since_IN 1990_CD ,_, the_DT worldwide_NN number_NN of_IN cases_NNS of_IN hookworm_NN was_VBD recently_RB estimated_VBN to_TO
        be_VB 740_CD million_CD people_NNS [_NN 4_CD ]_NN ._. The_DT highest_JJS prevalence_NN of_IN hookworm_NN occurs_VBZ in_IN sub-_NN Saharan_NNP Africa_NNP
        and_CC eastern_JJ Asia_NNP (_( Figure_NN 1_LS )_) ._. High_JJ transmission_NN (_( defined_VBN below_IN )_) also_RB occurs_VBZ in_IN other_JJ areas_NNS
        of_IN rural_JJ poverty_NN in_IN the_DT tropics_NNS ,_, including_VBG southern_JJ China_NNP [_NN 5_CD ]_NN ,_, the_DT Indian_JJ subcontinent_NN [_NN 6_CD ]_NN ,_,
        and_CC the_DT Americas_NNPS [_NN 7_CD ]_NN ._. In_IN all_DT regions_NNS ,_, there_EX is_VBZ a_DT striking_JJ relationship_NN between_IN hookworm_NN
        prevalence_NN and_CC low_JJ socioeconomic_JJ status_NN (_( Figure_NN 2_LS )_) [_NN 4_CD ]_NN ._. Hookworm_NNP 's_POS neglected_VBN status_NN partly_RB
        reflects_VBZ its_PRP$ concentration_NN among_IN the_DT world_NN 's_POS poorest_JJS 2_CD ._. 7_CD billion_CD people_NNS who_WP live_VBP on_IN less_JJR
        than_IN $_$ 2_CD a_DT day_NN ._.
      
      
        Clinical_NNP Features_NNPS ,_, Epidemiology_NNP ,_, and_CC Disease_NNP Burden_NNP
        Hookworm_NNP infection_NN is_VBZ acquired_VBN by_IN invasion_NN of_IN the_DT infective_JJ larval_NN stages_NNS through_IN the_DT
        skin_NN (_(
        A_DT ._. duodenale_NN larvae_NN are_VBP also_RB orally_RB infective_JJ )_) ._. Following_VBG host_NN
        entry_NN ,_, the_DT larvae_NN undergo_VBP a_DT journey_NN through_IN the_DT vasculature_NN ,_, then_RB the_DT lungs_NNS and_CC other_JJ
        tissues_NNS ,_, before_IN they_PRP enter_VBP the_DT gastrointestinal_NN tract_NN and_CC molt_NN twice_RB to_TO become_VB
        one-centimeter-long_JJ adult_NN male_JJ and_CC female_JJ worms_NNS [_NN 3_CD ]_NN ._. The_DT worms_NNS mate_NN and_CC the_DT female_JJ
        hookworms_NNS produce_VBP up_IN to_TO 30_CD ,_, 000_CD eggs_NNS per_IN day_NN ,_, which_WDT exit_NN the_DT host_NN 's_POS body_NN in_IN the_DT feces_NNS
        (_( Figure_NN 3_LS )_) ._.
        Because_IN hookworms_NNS do_VBP not_RB replicate_VB in_IN humans_NNS ,_, the_DT morbidity_NN of_IN hookworm_NN is_VBZ highest_JJS among_IN
        patients_NNS that_WDT harbor_NN large_JJ numbers_NNS of_IN adult_NN parasites_NNS ._. Estimates_NNS of_IN the_DT intensity_NN of_IN
        hookworm_NN infection_NN are_VBP typically_RB obtained_VBN by_IN using_VBG quantitative_JJ fecal_JJ egg_NN counts_VBZ as_IN a_DT
        surrogate_JJ marker_NN for_IN worm_NN burden_NN ._. The_DT World_NNP Health_NNP Organization_NNP defines_VBZ moderate-intensity_JJ
        infections_NNS as_IN those_DT with_IN 2_CD ,_, 000_CD –_NN 3_CD ,_, 999_CD eggs_NNS per_IN gram_NN of_IN feces_NNS ,_, and_CC heavy-intensity_JJ infections_NNS
        as_IN those_DT with_IN 4_CD ,_, 000_CD or_CC more_JJR eggs_NNS per_IN gram_NN (_( p_NN ._. 26_CD in_IN [_NN 8_CD ]_NN )_) ._. Compared_VBN to_TO other_JJ STH_NNP infections_NNS
        and_CC schistosomiasis_NNS ,_, hookworm_NN infection_NN exhibits_VBZ a_DT unique_JJ age-intensity_JJ profile—whereas_NNS the_DT
        intensities_NNS for_IN the_DT former_JJ peak_NN in_IN childhood_NN and_CC adolescence_NN ,_, hookworm_NN intensity_NN usually_RB
        either_CC steadily_RB rises_VBZ in_IN intensity_NN with_IN age_NN or_CC plateaus_JJ in_IN adulthood_NN [_NN 3_CD ,_, 9_CD ]_NN ._. The_DT biological_JJ
        basis_NN for_IN this_DT observation_NN is_VBZ unknown_JJ [_NN 10_CD ]_NN ._.
        Adult_NNP hookworms_NNS cause_VBP morbidity_NN in_IN the_DT host_NN by_IN producing_VBG intestinal_NN hemorrhage_NN [_NN 3_CD ]_NN ._. The_DT
        adult_NN hookworms_NNS then_RB ingest_VB the_DT blood_NN ,_, rupture_NN the_DT erythrocytes_NNS ,_, and_CC degrade_NN the_DT hemoglobin_NN
        [_NN 11_CD ]_NN ._. Therefore_RB ,_, the_DT disease_NN attributed_VBD to_TO hookworm_NN is_VBZ silent_JJ blood_NN loss_NN leading_VBG to_TO iron_VB
        deficiency_NN anemia_NN and_CC protein_NN malnutrition_NN ._. There_EX is_VBZ a_DT correlation_NN between_IN parasite_NN
        intensity_NN and_CC host_NN intestinal_NN blood_NN loss_NN [_NN 12_CD ]_NN ;_: in_IN children_NNS ,_, women_NNS of_IN reproductive_JJ age_NN ,_, and_CC
        other_JJ populations_NNS with_IN low_JJ iron_NN stores_NNS ,_, there_EX is_VBZ often_RB a_DT correlation_NN between_IN parasite_NN
        intensity_NN and_CC reductions_NNS in_IN host_NN hemoglobin_NN [_NN 3_CD ,_, 12_CD ,_, 13_CD ,_, 14_CD ,_, 15_CD ,_, 16_CD ]_NN ._. In_IN children_NNS ,_, chronic_JJ
        heavy-intensity_JJ infections_NNS are_VBP associated_VBN with_IN growth_NN retardation_NN ,_, as_RB well_RB as_IN intellectual_JJ
        and_CC cognitive_JJ impairments_NNS ;_: in_IN pregnant_JJ women_NNS ,_, they_PRP are_VBP associated_VBN with_IN adverse_JJ
        maternal–fetal_NN outcomes_NNS [_NN 3_CD ,_, 12_CD ,_, 13_CD ,_, 14_CD ,_, 15_CD ,_, 16_CD ]_NN ._.
        When_WRB measured_VBN in_IN disability-adjusted_JJ life_NN years_NNS ,_, the_DT global_JJ disease_NN burden_NN from_IN hookworm_NN
        exceeds_VBZ all_DT other_JJ major_JJ tropical_JJ infectious_JJ diseases_NNS with_IN the_DT exception_NN of_IN malaria_NN ,_,
        leishmaniasis_NNS ,_, and_CC lymphatic_JJ filariasis_NNS (_( pp_NN ._. 192_CD –_NN 193_CD in_IN [_NN 17_CD ]_NN )_) ._. In_IN addition_NN ,_, hookworm_NN has_VBZ
        been_VBN associated_VBN with_IN impaired_VBN learning_VBG ,_, increased_VBN absences_NNS from_IN school_NN ,_, and_CC decreased_VBD
        future_JJ economic_JJ productivity_NN [_NN 18_CD ]_NN ._. Therefore_RB ,_, like_IN other_JJ neglected_VBN diseases_NNS ,_, chronic_JJ
        infection_NN with_IN hookworm_NN promotes_VBZ long-term_JJ disability_NN and_CC increases_VBZ the_DT likelihood_NN that_IN an_DT
        afflicted_VBN population_NN will_MD remain_VB mired_VBN in_IN poverty_NN ._.
      
      
        Hookworm_NNP Control_NNP Strategies_NNS
        Because_IN of_IN its_PRP$ high_JJ transmission_NN potential_JJ ,_, hookworm_NN has_VBZ proven_VBN to_TO be_VB extremely_RB
        difficult_JJ to_TO eliminate_VB or_CC eradicate_VB in_IN areas_NNS of_IN poverty_NN and_CC poor_JJ sanitation_NN [_NN 19_CD ]_NN ._. Indeed_RB ,_,
        in_IN the_DT absence_NN of_IN comprehensive_JJ economic_JJ development_NN ,_, the_DT impact_NN of_IN sanitation_NN ,_, footwear_NN ,_,
        and_CC health_NN education_NN has_VBZ been_VBN minimal_JJ [_NN 19_CD ]_NN ._. Control_NN efforts_NNS have_VBP therefore_RB shifted_VBN to_TO
        reducing_VBG morbidity_NN through_IN mass_NN treatment_NN (_( also_RB known_VBN as_IN “ deworming_VBG” )_) of_IN affected_VBN
        populations_NNS with_IN anthelminthic_JJ drugs_NNS [_NN 19_CD ]_NN ._.
        Although_IN benzimidazoles_NNS (_( BZAs_NNP )_) are_VBP the_DT most_RBS commonly_RB used_VBN agents_NNS for_IN treating_VBG STH_NNP
        infections_NNS ,_, levamisole_NN and_CC pyrantel_NN may_MD also_RB be_VB used_VBN in_IN some_DT circumstances_NNS ._. Periodic_NNP and_CC
        repeated_VBN deworming_VBG with_IN BZAs_NNP and_CC praziquantel_NN ,_, complemented_JJ by_IN basic_JJ sanitation_NN and_CC
        adequate_JJ safe_JJ water_NN ,_, is_VBZ considered_VBN the_DT most_RBS cost-effective_JJ means_VBZ to_TO control_VB the_DT morbidity_NN
        caused_VBN by_IN STH_NNP and_CC schistosome_NN infections_NNS [_NN 19_CD ,_, 20_CD ,_, 21_CD ,_, 22_CD ]_NN ._. Efforts_NNS led_VBN by_IN the_DT World_NNP Health_NNP
        Organization_NNP have_VBP focused_VBN on_IN annual_JJ ,_, twice-yearly_JJ ,_, or_CC thrice-yearly_JJ doses_NNS in_IN schools_NNS
        because_IN the_DT heaviest_JJS intensities_NNS of_IN STH_NNP infections_NNS are_VBP most_RBS commonly_RB encountered_VBD in_IN
        school-age_JJ children_NNS [_NN 23_CD ]_NN ._.
        Among_IN the_DT health_NN benefits_NNS of_IN periodic_JJ deworming_VBG of_IN schoolchildren_NN are_VBP improvements_NNS in_IN
        iron_NN and_CC hemoglobin_NN status_NN ,_, physical_JJ growth_NN and_CC fitness_NN ,_, and_CC cognition_NN [_NN 20_CD ,_, 21_CD ,_, 22_CD ,_, 23_CD ]_NN ._. In_IN
        addition_NN ,_, there_EX are_VBP important_JJ externalities_NNS ,_, including_VBG improvements_NNS in_IN education_NN and_CC
        reduced_VBN community-based_JJ transmission_NN of_IN ascaris_NNS and_CC trichuris_NNS infections_NNS [_NN 23_CD ]_NN ._. Accordingly_RB ,_,
        at_IN the_DT 54_CD th_NN World_NNP Health_NNP Assembly_NNP in_IN 2001_CD ,_, a_DT resolution_NN was_VBD passed_VBN urging_VBG member_NN states_NNS to_TO
        attain_VB a_DT minimum_JJ target_NN of_IN regular_JJ deworming_VBG of_IN at_IN least_JJS 75_CD %_NN and_CC up_IN to_TO 100_CD %_NN of_IN all_DT at-risk_JJ
        school-age_JJ children_NNS by_IN 2010_CD [_NN 20_CD ,_, 23_CD ]_NN ._.
      
      
        Developing_VBG a_DT New_NNP Control_NNP Tool_NNP :_: The_DT Na-_NNP ASP-_NNP 2_CD Hookworm_NNP Vaccine_NNP
        Deworming_NNP satisfies_VBZ a_DT number_NN of_IN United_NNP Nations_NNPS Millennium_NNP Development_NNP Goals_NNP including_VBG
        those_DT related_VBN to_TO poverty_NN reduction_NN ,_, child_NN health_NN ,_, and_CC education_NN ._. However_RB ,_, there_EX are_VBP also_RB
        several_JJ reasons_NNS to_TO believe_VB that_IN the_DT school-based_JJ deworming_VBG programs_NNS could_MD have_VB less_JJR of_IN an_DT
        impact_NN on_IN the_DT control_NN of_IN morbidity_NN from_IN hookworm_NN than_IN from_IN other_JJ STH_NNP and_CC schistosome_NN
        infections_NNS [_NN 3_CD ]_NN ._. As_IN noted_VBD above_IN ,_, heavy-intensity_JJ hookworm_NN infections_NNS are_VBP common_JJ among_IN both_DT
        adults_NNS and_CC children_NNS ,_, so_RB school-based_JJ programs_NNS would_MD not_RB be_VB expected_VBN to_TO have_VB an_DT impact_NN on_IN
        hookworm_NN transmission_NN in_IN the_DT community_NN [_NN 24_CD ]_NN ._. School-based_NNP programs_NNS are_VBP also_RB not_RB likely_JJ to_TO
        affect_VB either_CC preschool_JJ children_NNS or_CC pregnant_JJ women_NNS ,_, despite_IN evidence_NN for_IN the_DT health_NN
        benefits_NNS from_IN BZAs_NNP in_IN both_DT populations_NNS [_NN 16_CD ,_, 25_CD ]_NN ._. Finally_RB ,_, a_DT single_JJ dose_NN of_IN mebendazole_NN (_( one_CD
        of_IN the_DT two_CD major_JJ BZAs_NNP )_) has_VBZ variable_JJ efficacy_NN against_IN hookworm_NN [_NN 26_CD ]_NN ,_, and_CC following_VBG
        treatment_NN ,_, hookworm_NN reinfection_NN to_TO pre-treatment_JJ levels_NNS can_MD occur_VB within_IN 4_CD –_NN 12_CD months_NNS [_NN 27_CD ]_NN ._.
        This_DT ,_, and_CC the_DT observation_NN that_IN the_DT efficacy_NN of_IN mebendazole_NN against_IN hookworm_NN can_MD diminish_VB
        with_IN frequent_JJ and_CC repeated_VBN use_NN ,_, has_VBZ prompted_VBN concerns_NNS about_IN the_DT possible_JJ emergence_NN of_IN BZA_NNP
        resistance_NN [_NN 28_CD ]_NN ._.
        As_IN a_DT complementary_JJ strategy_NN ,_, the_DT Human_NNP Hookworm_NNP Vaccine_NNP Initiative_NNP (_( HHVI_NNP )_) is_VBZ developing_VBG
        a_DT safe_JJ ,_, efficacious_JJ ,_, and_CC cost-effective_JJ vaccine_NN ,_, the_DT 
        Na_NNP -_: ASP-_NNP 2_CD Hookworm_NNP Vaccine_NNP ,_, that_WDT would_MD provide_VB an_DT additional_JJ tool_NN for_IN the_DT
        control_NN of_IN hookworm_NN [_NN 29_CD ,_, 30_CD ]_NN ._. The_DT HHVI_NNP is_VBZ a_DT non-profit_JJ partnership_NN comprising_VBG research_NN ,_,
        process_NN development_NN ,_, vaccine_NN manufacturing_NN and_CC control_NN ,_, and_CC pre-clinical_JJ and_CC clinical_JJ
        testing_NN units_NNS at_IN the_DT George_NNP Washington_NNP University_NNP ,_, London_NNP School_NNP of_IN Hygiene_NNP and_CC Tropical_NNP
        Medicine_NNP ,_, and_CC Oswaldo_NNP Cruz_NNP Foundation_NNP (_( FIOCRUZ_NNP )_) ,_, and_CC sponsored_VBN by_IN the_DT Sabin_NNP Vaccine_NNP
        Institute_NNP (_( www_NN ._. sabin_NN ._. org_NN )_) ._.
        The_DT HHVI_NNP selected_VBD the_DT hookworm_NN larval_NN antigen_NN ASP-_NNP 2_CD (_( ancylostoma_NN secreted_JJ protein-_NN 2_LS )_)
        based_VBN on_IN studies_NNS that_IN (_( 1_LS )_) identified_VBD the_DT molecule_NN as_IN a_DT protective_JJ antigen_NN linked_VBN to_TO
        earlier-generation_JJ irradiated_JJ infective_JJ larval_NN vaccines_NNS [_NN 29_CD ]_NN ,_, (_( 2_LS )_) determined_VBD a_DT relationship_NN
        between_IN human_JJ anti-_NN ASP-_NNP 2_CD antibodies_NNS and_CC reduced_VBN risk_NN of_IN heavy_JJ hookworm_NN infection_NN in_IN
        populations_NNS living_VBG in_IN hookworm-endemic_JJ regions_NNS of_IN Brazil_NNP and_CC China_NNP (_( [_NN 30_CD ]_NN ;_: J_NNP ._. Bethony_NNP ,_, A_DT ._.
        Loukas_NNP ,_, M_NNP ._. J_NNP ._. Smout_NNP ,_, S_NNP ._. Brooker_NNP ,_, S_NNP ._. Mendez_NNP ,_, et_CC al_NN ._. ,_, unpublished_JJ data_NNS )_) ,_, and_CC (_( 3_LS )_) confirmed_VBD
        the_DT ability_NN of_IN recombinant_JJ ASP-_NNP 2_CD to_TO partially_RB protect_VB laboratory_NN animals_NNS against_IN larval_NN
        hookworm_NN challenges_NNS [_NN 30_CD ,_, 31_CD ,_, 32_CD ]_NN ._.
        Process_NNP development_NN ,_, cGMP_NN manufacture_NN and_CC control_VB ,_, and_CC pre-clinical_JJ testing_NN of_IN 
        Na_NNP -_: ASP-_NNP 2_CD from_IN 
        N_NNP ._. americanus_JJ were_VBD completed_VBN in_IN 2004_CD (_( Figure_NN 4_LS )_) ._. Pending_NNP United_NNP
        States_NNPS Food_NNP and_CC Drug_NNP Administration_NNP approval_NN ,_, clinical_JJ testing_NN of_IN the_DT vaccine_NN will_MD take_VB
        place_NN in_IN 2005_CD ._. The_DT 
        Na_NNP -_: ASP-_NNP 2_CD Hookworm_NNP Vaccine_NNP will_MD be_VB developed_VBN almost_RB entirely_RB in_IN the_DT
        non-profit_JJ sector_NN ._. Ultimately_RB ,_, the_DT vaccine_NN will_MD be_VB indicated_VBN for_IN the_DT active_JJ immunization_NN of_IN
        susceptible_JJ individuals_NNS against_IN moderate_JJ and_CC heavy_JJ necator_NN infection_NN ._. Vaccination_NNP would_MD
        reduce_VB the_DT number_NN of_IN hookworm_NN infective_JJ larvae_NN entering_VBG the_DT gastrointestinal_NN tract_NN ,_, thereby_RB
        reducing_VBG the_DT number_NN of_IN adult_NN worms_NNS and_CC the_DT fecal_JJ egg_NN counts_VBZ in_IN individuals_NNS exposed_VBN to_TO the_DT
        larvae_NN ._.
      
      
        Hookworm_NNP as_IN a_DT Model_NNP
        Because_IN immunization_NN would_MD only_RB affect_VB hookworm_NN larvae_NN and_CC not_RB adult_NN hookworms_NNS already_RB
        residing_VBG in_IN the_DT gastrointestinal_NN tract_NN of_IN infected_JJ individuals_NNS ,_, the_DT first_JJ dose_NN of_IN the_DT
        vaccine_NN would_MD be_VB administered_VBN following_VBG deworming_VBG ._. Therefore_RB ,_, use_NN of_IN the_DT vaccine_NN could_MD
        build_VB on_IN the_DT infrastructures_NNS developed_VBN as_IN part_NN of_IN school-based_JJ programs_NNS ._. Given_VBN that_DT
        hookworm_NN afflicts_VBZ only_RB the_DT world_NN 's_POS most_RBS impoverished_VBN ,_, a_DT major_JJ hurdle_NN for_IN the_DT development_NN of_IN
        the_DT 
        Na_NNP -_: ASP-_NNP 2_CD Hookworm_NNP Vaccine_NNP is_VBZ its_PRP$ small_JJ commercial_JJ market_NN ._. Innovative_JJ
        financing_NN mechanisms_NNS must_MD be_VB considered_VBN to_TO produce_VB this_DT orphan_JJ biologic_JJ ._. Towards_NNP that_DT end_NN ,_,
        the_DT HHVI_NNP has_VBZ partnered_JJ with_IN manufacturers_NNS in_IN hookworm-endemic_JJ middle-income_JJ countries_NNS that_WDT
        would_MD commit_VB to_TO industrial_JJ scale-up_JJ of_IN the_DT 
        Na_NNP -_: ASP-_NNP 2_CD Hookworm_NNP Vaccine_NNP pending_VBG proof-of-principle_JJ for_IN its_PRP$ efficacy_NN ._.
        This_DT approach_NN might_MD help_VB to_TO inform_VB the_DT development_NN of_IN business_NN models_NNS for_IN the_DT production_NN
        and_CC distribution_NN of_IN orphan_JJ biologics_NNS for_IN other_JJ neglected_VBN diseases_NNS ._.
      
    
  
